Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2023 Earnings Call Transcript May 12, 2023
Adaptimmune Therapeutics plc beats earnings expectations. Reported EPS is $0.01, expectations were $-0.14.
Operator: Hello. Welcome to Adaptimmune’s First Quarter Call and Business Update. I would now like to turn the call over to Juli Miller. Juli, please go ahead.
Juli Miller: Good morning, and welcome to Adaptimmune’s conference call to discuss our first quarter 2023 financial results and business...
